Lonza
Lonza’s Vision for the Future: A Fireside Chat with New CEO Wolfgang Wienand
Lonza, Wolfgang Wienand, CDMO, Pharmaceutical manufacturing, Biologics, Cell and gene therapy, Small molecules, Leadership transition, Industry outlook
Lonza Expands Gelatin Capsule Production in India and China Amid Plans to Exit Capsules Business
Lonza, Capsules & Health Ingredients, Gelatin Capsules, India, China, Expansion, Exit Strategy
Lonza Announces Strategic Shift to Focus on CDMO Business, Exits Capsules & Health Ingredients
Lonza, CDMO, Capsules & Health Ingredients, Restructure, One Lonza Strategy
Lonza Acquires Roche’s Massive Biologics Production Facility in Vacaville, California for $1.2 Billion
Lonza, Roche, Genentech, Biologics Manufacturing Site, Vacaville/ California, $1.2 Billion Deal, Large-Scale Commercial Mammalian Products, Expansion Plans ($561 Million), Capacity Utilization, Contract Development and Manufacturing Organizations (CDMOs), Global Biologics Market Growth